yourstate.us
Kan. Stat. Ann. § 76-835

Midwest stem cell therapy center; powers, duties and functions

Kansas · Kansas Statutes Annotated Chapter 76 — State Institutions and Agencies; Historical Property · Status: effective

Get this as JSONEmbed this
Cite this
Citation
Kan. Stat. Ann. § 76-835, Midwest stem cell therapy center; powers, duties and functions, Kansas, version 1 as recorded 2026-10-04, yourstate.us, https://yourstate.us/provision/2612205
Permanent ID
ys:prov:2612205@1
SHA-256
b849a2311bb5a5cace418c4dd383fb9bb72de486e547474f30e25cc8d2902fc9

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) The university of Kansas medical center shall establish the midwest stem cell therapy center. The center shall: (1) Focus on activities that advance adult, cord blood and related stem cell and non-embryonic stem cell research and therapies for patient treatment; (2) serve as a core facility to produce clinical grade stem cells from adult tissues, cord blood and related materials for use in clinical trials and therapies; (3) facilitate the delivery of adult, cord blood and related stem cell therapies to Kansas City and midwest region hospitals where appropriate; (4) partner and collaborate with the blood and marrow transplant center of Kansas to foster a regional network of physicians trained in adult, cord blood and related stem cell therapy applications; (5) create and maintain a database resource for physicians and patients that provides a comprehensive global list of available stem cell clinical trials and therapies; (6) initiate clinical trials with adult, cord blood and related stem cells; (7) create education modules to train and educate physicians and research scientists about peer-reviewed adult, cord blood and related stem cell therapy applications for patients; (8) distribute information to Kansas physicians about methods for successful treatments with adult, cord blood and related stem cells through basic and clinical research; and (9) inform the public on available adult, cord blood and related stem cell therapeutic options.